Dinutuximab (Anti-GD2)

Synonyms: monoclonal antibody Ch14.18

Dinutuximab (Anti-GD2) is a chimeric mouse/human monoclonal antibody that targets ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. It has potential antineoplastic activity. MW: 145.5 KD.

Dinutuximab (Anti-GD2)

Purity & Quality Control

Batch: A248501 Purity: 99% Protein concentration: 11.26mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Dinutuximab (Anti-GD2) is a chimeric mouse/human monoclonal antibody that targets ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. It has potential antineoplastic activity. MW: 145.5 KD.

Product Details

CAS No. 1363687-32-4 
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) supplier | purchase Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) cost | Dinutuximab (Anti-GD2) manufacturer | order Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) distributor